Plant upgrade to lower supply of Merck's adult HBV shot

01/7/2009 | Philadelphia Inquirer, The

Merck & Co. announced an impending shortage of the adult version of Recombivax HB, its hepatitis B vaccine, because of improvements to its West Point, Pa., facility. The shortfall does not include the pediatric formulation and is not linked to an FDA warning issued in April about production issues at the plant, a Merck spokeswoman said. GlaxoSmithKline is making enough vaccines to address the shortage, the CDC said.

View Full Article in:

Philadelphia Inquirer, The

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Director of Actuarial Services, Government Programs
Springfield, OR
Director, Health Plan Claims Operations
Group Health Cooperative
Seattle, WA
Senior Director, Research
America's Health Insurance Plans (AHIP)
Washington, DC
Stop Loss Sales Executive
Blue Cross Blue Shield of MA
Boston, MA
Regional Director, Southeastern Region - State Affairs
America's Health Insurance Plans (AHIP)
Washington, DC